+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Expansion Market by Cell Type, Application, Technology, End User, Scale - Global Forecast to 2030- Product Image
Cell Expansion Market by Cell Type, Application, Technology, End User, Scale - Global Forecast to 2030- Product Image
Sale

Cell Expansion Market by Cell Type, Application, Technology, End User, Scale - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4995206
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cell Expansion Market grew from USD 20.90 billion in 2024 to USD 22.72 billion in 2025. It is expected to continue growing at a CAGR of 8.29%, reaching USD 33.73 billion by 2030.

Unveiling the Cell Expansion Frontier

Cell expansion stands at the core of transformative advances in biotechnology and regenerative medicine, offering the promise of scalable cell production for therapeutic, research, and industrial applications. From the cultivation of stem cells to support tissue engineering to the generation of immune cells for next-generation therapies, the process of expanding viable cell populations underpins breakthroughs in health care and scientific discovery. Rapid innovations in bioreactor design, culture platforms, and process automation continue to redefine production efficiency, enabling researchers and manufacturers to address critical shortages and meet rising demand for high-quality cellular products.

This executive summary distills key findings from a comprehensive analysis of the global cell expansion market, presenting actionable insights into current dynamics, disruptive trends, and strategic imperatives. It outlines the major technological developments, regulatory shifts, and economic factors shaping the industry landscape. By highlighting segmentation patterns, regional strengths, and the competitive positioning of leading companies, this report equips decision-makers with the clarity needed to navigate market complexities and seize emerging opportunities.

Paradigm Shifts Reshaping the Cell Expansion Ecosystem

The cell expansion ecosystem is experiencing a profound transformation driven by innovative technologies and shifting research priorities. Single-use bioreactors and perfusion systems have curtailed contamination risks and accelerated scale-up processes, while advanced microcarriers optimized surface area and shear conditions to boost cell yield. In parallel, the integration of sensor-based analytics and machine learning has ushered in real-time monitoring and adaptive control protocols, delivering unprecedented process consistency and reducing time to market.

Regenerative medicine and immunotherapy have further catalyzed market evolution by demanding highly specialized cell products with stringent quality attributes. Chimeric antigen receptor T cell therapy and natural killer cell therapy, for example, require refined expansion platforms capable of preserving cell phenotype and potency at scale. As strategic alliances emerge between academic institutions and contract manufacturers, the industry is poised to accelerate commercialization pathways and refine manufacturing philosophies that align with personalized medicine objectives.

Assessing the Ramifications of 2025 United States Tariffs

The implementation of new United States tariffs in 2025 on key bioprocessing materials and equipment has introduced complex challenges for global cell expansion stakeholders. Companies reliant on imported microcarriers, perfusion filters, and advanced reactor components have encountered elevated input costs, prompting a reassessment of supply chains. This repricing has led some manufacturers to explore alternative suppliers in tariff-exempt regions or to invest in domestic production capabilities, reshaping traditional procurement strategies.

Despite the initial cost pressures, the tariffs have spurred long-term strategic shifts toward regional diversification and nearshoring. Organizations are renegotiating contracts, consolidating orders, and collaborating with logistics partners to mitigate the impact of escalating duties. In many cases, these adjustments have fostered greater supply chain resilience and provided an impetus for investment in local infrastructure, ultimately strengthening the market’s capacity to respond to future trade fluctuations.

Decoding Market Segmentation Dynamics

Differentiating markets by cell type reveals two principal streams: adherent cells and suspension cells. Adherent cell workflows continue to evolve from traditional two-dimensional surfaces to microcarrier-based systems, which facilitate increased surface area and more efficient scale-up. Suspension cells, meanwhile, encompass insect, mammalian, and stem cell lines, with the latter category demanding further specialization. Within stem cells, human pluripotent and mesenchymal stem cells command distinct culture requirements, influencing the choice of bioreactor and media platforms.

When examining applications, cell banking underpins long-term storage solutions, while immunotherapy applications such as chimeric antigen receptor T cell therapy and natural killer cell therapy demonstrably heighten market growth through breakthrough clinical successes. Regenerative medicine leverages expanded cells for tissue reconstruction, and research and development activities, including drug screening and toxicology studies, rely on consistent high-throughput expansion systems. Meanwhile, technology segmentation underscores the dominance of bioreactors-spanning fixed bed, hollow fiber, stirred tank, and wave designs-alongside the critical roles of microcarriers and perfusion systems, which incorporate alternating tangential flow, spin filter, and tangential flow filtration modules. End users distribute across academic research institutes, biotechnology innovators, contract manufacturing organizations, and large pharmaceutical companies, each demanding tailored process solutions. Finally, scale distinctions between bench, pilot, and commercial levels define distinct performance benchmarks and capital investment profiles.

Mapping Regional Strengths and Opportunities

Regional dynamics in the Americas reflect a robust ecosystem anchored by leading cell therapy pioneers and extensive contract manufacturing infrastructure. North America benefits from substantial research funding, streamlined regulatory pathways, and a well-established bioprocessing supply chain, driving high adoption rates of advanced expansion platforms. Latin America, although emerging, shows incremental growth potential through targeted investments in regenerative medicine initiatives and collaborative projects between public and private sectors.

The Europe, Middle East & Africa region presents a heterogeneous landscape, where established markets such as Germany, the United Kingdom, and France propel innovation in adherent cell culture and immunotherapies. Simultaneously, the Middle East and Africa are gradually building capacity through strategic partnerships and government-sponsored biotech clusters. In the Asia-Pacific, rapid industrialization and supportive government policies in China, Japan, and South Korea have fueled large-scale manufacturing investments and local bioreactor production, positioning the region as a critical nexus for future cell expansion growth.

Profiling Industry Pioneers Driving Growth

Leading players are leveraging strategic acquisitions, proprietary technology development, and collaborative partnerships to capture value across the cell expansion continuum. Major equipment manufacturers have introduced next-generation bioreactors and closed-system microcarrier platforms, enhancing scalability while reducing contamination risks. At the same time, specialized biotechnology firms are innovating stem cell expansion protocols and perfusion systems tailored to immunotherapy applications, reinforcing their competitive positions.

Contract manufacturing organizations are expanding facility footprints and diversifying service portfolios to meet demand from both established pharmaceutical companies and emerging cell therapy ventures. Additionally, cross-sector collaborations between academic research institutes and industry partners continue to accelerate process validation and regulatory submissions, reducing time-to-clinic for novel cellular therapies. These combined efforts underscore a market driven by technological leadership and integrated service offerings.

Strategic Imperatives for Industry Leadership

Industry leaders must prioritize the adoption of integrated, flexible manufacturing platforms capable of transitioning seamlessly from pilot to commercial scale. Investing in modular bioprocessing units and automated quality control systems will enable faster response to demand fluctuations and enhance process reproducibility. Furthermore, building strategic alliances with reagent suppliers and analytics providers can secure preferential access to critical inputs and ensure real-time operational insights.

Companies should also evaluate opportunities to localize production in key markets, mitigating the impact of trade barriers and reducing lead times. Emphasizing workforce training and implementing standardized operational protocols will foster a culture of quality and regulatory compliance. Finally, exploring co-development partnerships with academic institutions can accelerate the translation of novel expansion methodologies into scalable, market-ready solutions.

Rigorous Methodology Underpinning Our Analysis

This analysis integrates primary interviews with process engineers, regulatory experts, and senior executives across the cell expansion value chain. Secondary research encompassed peer-reviewed journals, industry white papers, and proprietary databases to verify technological developments, market trends, and competitive strategies. Segmentation frameworks were validated through cross-referencing public filings, patent landscapes, and conference proceedings to ensure comprehensive coverage of cell type, application, technology, end user, and scale dimensions.

Quantitative data sets were triangulated using supply chain shipment records, pricing indices, and clinical trial registries. All insights underwent rigorous peer review and statistical validation to confirm accuracy and reliability. This robust methodology underpins the credibility of the report’s conclusions and delivers a dependable foundation for strategic decision-making.

Synthesis of Executive Insights

The cell expansion market is undergoing rapid evolution, driven by technological innovation, regulatory shifts, and global economic dynamics. Emerging paradigms in bioreactor design, process automation, and single-use systems are redefining production efficiencies, while tariff-related supply chain realignments are prompting deeper regionalization of manufacturing capabilities. These forces converge to create both challenges and opportunities for stakeholders across the ecosystem.

By synthesizing segmentation insights, regional strengths, and competitive strategies, this executive summary provides a clear roadmap for organizations seeking to capitalize on the accelerating growth of cell expansion. The ongoing commitment to process excellence and strategic collaboration will determine which players lead the next wave of innovations and commercial successes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Cell Type
    • Adherent Cells
      • Microcarrier Based
      • Two Dimensional Culture
    • Suspension Cells
      • Insect
      • Mammalian
      • Stem Cells
        • Human Pluripotent Stem Cells
        • Mesenchymal Stem Cells
  • Application
    • Cell Banking
    • Immunotherapy
      • Chimeric Antigen Receptor T Cell Therapy
      • Natural Killer Cell Therapy
    • Regenerative Medicine
    • Research And Development
      • Drug Screening
      • Toxicology Studies
  • Technology
    • Bioreactors
      • Fixed Bed Bioreactors
      • Hollow Fiber Bioreactors
      • Stirred Tank Bioreactors
      • Wave Bioreactors
    • Microcarriers
    • Perfusion Systems
      • Alternating Tangential Flow Systems
      • Spin Filter Systems
      • Tangential Flow Filtration
  • End User
    • Academic Research Institutes
    • Biotechnology Companies
    • Contract Manufacturing Organizations
    • Pharmaceutical Companies
  • Scale
    • Bench Scale
    • Commercial Scale
    • Pilot Scale
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Sartorius AG
  • Danaher Corporation
  • Lonza Group AG
  • Miltenyi Biotec GmbH
  • STEMCELL Technologies Inc.
  • Eppendorf AG
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cell Expansion Market, by Cell Type
8.1. Introduction
8.2. Adherent Cells
8.2.1. Microcarrier Based
8.2.2. Two Dimensional Culture
8.3. Suspension Cells
8.3.1. Insect
8.3.2. Mammalian
8.3.3. Stem Cells
8.3.3.1. Human Pluripotent Stem Cells
8.3.3.2. Mesenchymal Stem Cells
9. Cell Expansion Market, by Application
9.1. Introduction
9.2. Cell Banking
9.3. Immunotherapy
9.3.1. Chimeric Antigen Receptor T Cell Therapy
9.3.2. Natural Killer Cell Therapy
9.4. Regenerative Medicine
9.5. Research And Development
9.5.1. Drug Screening
9.5.2. Toxicology Studies
10. Cell Expansion Market, by Technology
10.1. Introduction
10.2. Bioreactors
10.2.1. Fixed Bed Bioreactors
10.2.2. Hollow Fiber Bioreactors
10.2.3. Stirred Tank Bioreactors
10.2.4. Wave Bioreactors
10.3. Microcarriers
10.4. Perfusion Systems
10.4.1. Alternating Tangential Flow Systems
10.4.2. Spin Filter Systems
10.4.3. Tangential Flow Filtration
11. Cell Expansion Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Biotechnology Companies
11.4. Contract Manufacturing Organizations
11.5. Pharmaceutical Companies
12. Cell Expansion Market, by Scale
12.1. Introduction
12.2. Bench Scale
12.3. Commercial Scale
12.4. Pilot Scale
13. Americas Cell Expansion Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cell Expansion Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cell Expansion Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. Sartorius AG
16.3.4. Danaher Corporation
16.3.5. Lonza Group AG
16.3.6. Miltenyi Biotec GmbH
16.3.7. STEMCELL Technologies Inc.
16.3.8. Eppendorf AG
16.3.9. Bio-Rad Laboratories, Inc.
16.3.10. Bio-Techne Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CELL EXPANSION MARKET MULTI-CURRENCY
FIGURE 2. CELL EXPANSION MARKET MULTI-LANGUAGE
FIGURE 3. CELL EXPANSION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CELL EXPANSION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CELL EXPANSION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CELL EXPANSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CELL EXPANSION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CELL EXPANSION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CELL EXPANSION MARKET SIZE, BY SCALE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CELL EXPANSION MARKET SIZE, BY SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CELL EXPANSION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CELL EXPANSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CELL EXPANSION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CELL EXPANSION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CELL EXPANSION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CELL EXPANSION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CELL EXPANSION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CELL EXPANSION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL EXPANSION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CELL EXPANSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CELL EXPANSION MARKET SIZE, BY MICROCARRIER BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CELL EXPANSION MARKET SIZE, BY TWO DIMENSIONAL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CELL EXPANSION MARKET SIZE, BY INSECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CELL EXPANSION MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CELL EXPANSION MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CELL EXPANSION MARKET SIZE, BY HUMAN PLURIPOTENT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CELL EXPANSION MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL BANKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CELL EXPANSION MARKET SIZE, BY CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CELL EXPANSION MARKET SIZE, BY NATURAL KILLER CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CELL EXPANSION MARKET SIZE, BY DRUG SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CELL EXPANSION MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CELL EXPANSION MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CELL EXPANSION MARKET SIZE, BY FIXED BED BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CELL EXPANSION MARKET SIZE, BY HOLLOW FIBER BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CELL EXPANSION MARKET SIZE, BY STIRRED TANK BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CELL EXPANSION MARKET SIZE, BY WAVE BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CELL EXPANSION MARKET SIZE, BY MICROCARRIERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CELL EXPANSION MARKET SIZE, BY ALTERNATING TANGENTIAL FLOW SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CELL EXPANSION MARKET SIZE, BY SPIN FILTER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CELL EXPANSION MARKET SIZE, BY TANGENTIAL FLOW FILTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CELL EXPANSION MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CELL EXPANSION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CELL EXPANSION MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CELL EXPANSION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CELL EXPANSION MARKET SIZE, BY BENCH SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CELL EXPANSION MARKET SIZE, BY COMMERCIAL SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CELL EXPANSION MARKET SIZE, BY PILOT SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS CELL EXPANSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES CELL EXPANSION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 78. CANADA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 79. CANADA CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 80. CANADA CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 81. CANADA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 82. CANADA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. CANADA CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 84. CANADA CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 85. CANADA CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. CANADA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 87. CANADA CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 88. CANADA CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. CANADA CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 90. MEXICO CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 91. MEXICO CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 92. MEXICO CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 93. MEXICO CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. MEXICO CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 96. MEXICO CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 97. MEXICO CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. MEXICO CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 99. MEXICO CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 100. MEXICO CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. MEXICO CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 152. GERMANY CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 153. GERMANY CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 154. GERMANY CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 155. GERMANY CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. GERMANY CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 157. GERMANY CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 158. GERMANY CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. GERMANY CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 160. GERMANY CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 161. GERMANY CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. GERMANY CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 163. FRANCE CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 164. FRANCE CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 165. FRANCE CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 166. FRANCE CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 167. FRANCE CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. FRANCE CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 169. FRANCE CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 170. FRANCE CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. FRANCE CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 172. FRANCE CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 173. FRANCE CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. FRANCE CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 187. ITALY CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 188. ITALY CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 189. ITALY CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 190. ITALY CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 191. ITALY CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. ITALY CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 193. ITALY CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 194. ITALY CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. ITALY CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 196. ITALY CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 197. ITALY CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. ITALY CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 199. SPAIN CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 200. SPAIN CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 201. SPAIN CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 202. SPAIN CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 203. SPAIN CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. SPAIN CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 205. SPAIN CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 206. SPAIN CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. SPAIN CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 208. SPAIN CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 209. SPAIN CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. SPAIN CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 247. DENMARK CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 248. DENMARK CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 249. DENMARK CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 250. DENMARK CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 251. DENMARK CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. DENMARK CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 253. DENMARK CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 254. DENMARK CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 255. DENMARK CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 256. DENMARK CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 257. DENMARK CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. DENMARK CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 271. QATAR CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 272. QATAR CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 273. QATAR CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 274. QATAR CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 275. QATAR CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. QATAR CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 277. QATAR CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 278. QATAR CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. QATAR CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 280. QATAR CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 281. QATAR CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. QATAR CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 283. FINLAND CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 284. FINLAND CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 285. FINLAND CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 286. FINLAND CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 287. FINLAND CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. FINLAND CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 289. FINLAND CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 290. FINLAND CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. FINLAND CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 292. FINLAND CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 293. FINLAND CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. FINLAND CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 305. SWEDEN CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. SWEDEN CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 313. NIGERIA CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 314. NIGERIA CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. NIGERIA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 316. NIGERIA CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 317. NIGERIA CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. NIGERIA CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 319. EGYPT CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 320. EGYPT CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 321. EGYPT CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 322. EGYPT CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 323. EGYPT CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. EGYPT CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 325. EGYPT CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 326. EGYPT CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 327. EGYPT CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 328. EGYPT CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 329. EGYPT CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 330. EGYPT CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 331. TURKEY CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 332. TURKEY CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 333. TURKEY CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 334. TURKEY CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 335. TURKEY CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 336. TURKEY CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 337. TURKEY CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 338. TURKEY CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 339. TURKEY CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 340. TURKEY CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 341. TURKEY CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 342. TURKEY CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 343. ISRAEL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 344. ISRAEL CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 345. ISRAEL CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 346. ISRAEL CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 347. ISRAEL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 348. ISRAEL CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 349. ISRAEL CELL EXPANSION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 350. ISRAEL CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 351. ISRAEL CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 352. ISRAEL CELL EXPANSION MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 353. ISRAEL CELL EXPANSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 354. ISRAEL CELL EXPANSION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 355. NORWAY CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 356. NORWAY CELL EXPANSION MARKET SIZE, BY ADHERENT CELLS, 2018-2030 (USD MILLION)
TABLE 357. NORWAY CELL EXPANSION MARKET SIZE, BY SUSPENSION CELLS, 2018-2030 (USD MILLION)
TABLE 358. NORWAY CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 359. NORWAY CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 360. NORWAY CELL EXPANSION MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 361.

Companies Mentioned

The companies profiled in this Cell Expansion market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Sartorius AG
  • Danaher Corporation
  • Lonza Group AG
  • Miltenyi Biotec GmbH
  • STEMCELL Technologies Inc.
  • Eppendorf AG
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 22.72 Billion
Forecasted Market Value ( USD ) by 2030 $ 33.73 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Serum-free T Cell Expansion Medium Market by Format, Technology, Application, Cell Type, End User - Global Forecast to 2030 - Product Image

Serum-free T Cell Expansion Medium Market by Format, Technology, Application, Cell Type, End User - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Cell Expansion - Global Strategic Business Report - Product Image

Cell Expansion - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Cell Expansion Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Image

Cell Expansion Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • 182 Pages
  • Global
From
Cell Expansion Market Report 2025 - Product Image

Cell Expansion Market Report 2025

  • Report
  • 200 Pages
  • Global
From
2025 Global Forecast for Cell Expansion Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Cell Expansion Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From

About the Cell Expansion Market

Cell Expansion is a biotechnology market that focuses on the development of technologies and products that enable the growth and expansion of cells. This includes the development of cell culture media, cell culture systems, and cell expansion systems. Cell expansion technologies are used in a variety of applications, such as drug discovery, cell therapy, and regenerative medicine. Cell expansion technologies are also used in research and development, as well as in the production of biopharmaceuticals. Cell expansion technologies are used to increase the number of cells in a culture, allowing for more efficient production of biopharmaceuticals. This technology also enables researchers to study the behavior of cells in different environments, as well as to develop new cell-based therapies. Cell expansion technologies are used in a variety of industries, including biotechnology, pharmaceuticals, and medical devices. Companies in this market include Thermo Fisher Scientific, Merck KGaA, Corning, Lonza, and Sartorius. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.